United Therapeutics Corporation (UTHR)
Operating profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 1,377,000 | 1,184,900 | 979,700 | 555,900 | 593,600 |
| Revenue | US$ in thousands | 2,877,400 | 2,327,500 | 1,936,300 | 1,685,500 | 1,483,300 |
| Operating profit margin | 47.86% | 50.91% | 50.60% | 32.98% | 40.02% |
December 31, 2024 calculation
Operating profit margin = Operating income ÷ Revenue
= $1,377,000K ÷ $2,877,400K
= 47.86%
United Therapeutics Corporation's operating profit margin has shown fluctuations over the past five years. It stood at 40.02% on December 31, 2020, dropped to 32.98% by December 31, 2021, but then exhibited a significant increase to 50.60% by December 31, 2022. The trend continued upwards, reaching 50.91% by December 31, 2023, before slightly decreasing to 47.86% by December 31, 2024.
Overall, the company experienced variability in its operating profit margin during this period, with a notable improvement in 2022 and 2023. It is essential for United Therapeutics Corporation to continue monitoring and managing its operating expenses and revenue generation to maintain a healthy and sustainable margin in the future.
Peer comparison
Dec 31, 2024